Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Societe Generale

Investor type Investment Bank
Founders Paulin Talabot


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 76
Average round size
The average size of a deal this fund participated in
Portfolio companies 65
Rounds per year 0.48
Lead investments 9
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 23
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Software
  • Financial Services
  • Information Technology
  • Energy
  • Internet

In 1864 was created Societe Generale, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Paris. The venture was found in Europe in France.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Software, Information Technology. Among the most popular portfolio startups of the fund, we may highlight Symphony Communication Services Holdings, Talan, QSecure.

Speaking about the real fund results, this Corporate Investor is 2 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. This Societe Generale works on 15 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of more than 100 millions dollars are the general things for fund. The top amount of exits for fund were in 2018. When the investment is from Societe Generale the average startup value is 100-500 millions dollars. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Societe Generale, startups are often financed by Worldview Technology Partners, Redpoint, AllegisCyber. The meaningful sponsors for the fund in investment in the same round are BNP Paribas Private Equity, Citigroup, Worldview Technology Partners. In the next rounds fund is usually obtained by Worldview Technology Partners, UMC Capital, AllegisCyber.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Societe Generale:
Typical Co-investors
Societe Generale is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Societe Generale:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BonVenture Bayern, Germany, Munich
Charitable Leadership Foundation Clifton Park, New York, United States
Chongqing Dongzheng Huaixin Guquan Touzi Jijin Hehuo Qiye (Youxian Hehuo) China, Chongqing, Jiulongpo
Cogito Ventures -
Corner Ventures California, Palo Alto, United States
Delphi VC New York, New York, United States
EDS-A.T. Kearney Ventures -
Guangdong Hongmi Touzi Hehuo Qiye (Putong Hehuo) China, Guangdong, Zhangshan
Invest In Visions -
MF Private Capital Boston, Massachusetts, United States
ODDO BHF France, Ile-de-France, Paris
Opium Ventures China, Hong Kong, Hong Kong Island
Pappas Capital Durham, North Carolina, United States
Ruian Real Estate Development Management China, Shanghai
Ruihuide Keji Touzi Beijing, Beijing, China
Saviu Ventures Ebène, Mauritius, Plaines Wilhems
Shinhan Capital Seoul, Seoul-t'ukpyolsi, South Korea
Sylvain & CO -
Yajie Shanghui Beijing, China, Haidian

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Freight Service
Last Mile Transportation
Supply Chain Management
$123M02 Mar 2023 Gurugram, Haryana, India

Hecate Grid

Power Grid
Renewable Energy
$98M07 Feb 2023 Chicago, Illinois, United States

Lightsource bp

Environmental Consulting
Renewable Energy
$267M18 Jan 2023 London, England, United Kingdom


Big Data
Financial Services
$12M15 Dec 2022 Paris, Ile-de-France, France

Vestiaire Collective

E-Commerce Platforms
Social Shopping
$88M13 Dec 2022 Paris, Ile-de-France, France


Online Portals
$44M22 Nov 2022 Mumbai, Maharashtra, India

BB Energy

Oil and Gas
$580M14 Nov 2022 London, England, United Kingdom


$30M03 Nov 2022 Paris, Ile-de-France, France

H2 Green Steel

Precious Metals
$4B24 Oct 2022 -
Provepharm Life Solution Raises €120M in Funding

– Provepharm Life Solutions, a Marseille-based pharmaceutical company that finds new applications for known molecules.
– The company raised €120M in funding.
Tikehau Capital will provide the funds joining the group’s pool of banking investors, including Société Générale, BNP Paribas, Banque Populaire Méditerranée, Crédit Agricole Alpes Provence and Bpifrance.
– The new investment will be used to consolidate its position as an international and independent pharmaceutical group, specifically by hiring new staff in France and the United States, and increasing the size of its laboratories in Marseille.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Societe Generale?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: